1. Home
  2. UFI vs PMN Comparison

UFI vs PMN Comparison

Compare UFI & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

N/A

Current Price

$6.10

Market Cap

76.4M

ML Signal

N/A

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

N/A

Current Price

$9.72

Market Cap

84.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UFI
PMN
Founded
1969
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Textiles
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
84.1M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
UFI
PMN
Price
$6.10
$9.72
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $42.71
AVG Volume (30 Days)
★ 53.2K
31.5K
Earning Date
11-03-2026
11-11-2026
Dividend Yield
★ 27.18%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $531,303,000.00
N/A
Revenue This Year
$4.12
N/A
Revenue Next Year
$9.69
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$0.29
52 Week High
$8.47
$27.40

Technical Indicators

Market Signals
Indicator
UFI
PMN
Relative Strength Index (RSI) 31.48 32.85
Support Level $5.95 $9.20
Resistance Level $6.79 $15.37
Average True Range (ATR) 0.21 0.96
MACD -0.04 -0.17
Stochastic Oscillator 1.33 15.34

Price Performance

Historical Comparison
UFI
PMN

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

Share on Social Networks: